PGR and neoplasm: In their study, Brand et al. found the following VTE predictive factors: older age, higher weight, history of previous VTE, comorbidities, tumor size greater than 4 cm, progesterone receptor-negative disease, more than four affected nodes, and chemo-endocrine therapy [26].